Skip to main content

Articles By Sheila Reyes, MD

many heads

ICYMI: Issues in AxSpA: Treatment Intensification, Pregnancy

A lot of interesting studies will be presented at the poster sessions on Sunday, November 12 and some of them address practical real-world issues such as treatment intensification and the impact of pregnancy on axSpA imaging. 

Read Article
back, LBP, spine, AS

Can Rheumatologists Accurately Diagnose axSpA in Patients with Chronic Back Pain?

Chronic low back pain is a common complaint that brings patients to the doctor’s attention. Although the majority of low back pain is mechanical in nature, an important minority is inflammatory in nature.

Read Article
DPGN, lupus, nephritis, GN, glomerulonephritis, biopsy, kidney

SGLT2 inhibitors: The new hype in SLE and LN management?

Inhibitors of SGLT2 have been shown to reduce MACE in patients with type 2 DM and established cardiovascular disease. In patients with chronic kidney disease at risk of progression, SGLT2 inhibitors have shown reduction in risk of eGFR decline and hospitalization. In SLE, clinical trials have yet to explore the possible role of SGLT2i in improving renal outcomes in lupus nephritis. A couple of abstracts presented during the meeting tackled the topic of SGLT2 inhibition in SLE. 

Read Article
many heads

Issues in AxSpA: Treatment Intensification, Pregnancy

A lot of interesting studies will be presented at the poster sessions on Sunday, November 12 and some of them address practical real-world issues such as treatment intensification and the impact of pregnancy on axSpA imaging. 

Read Article
Plaquenil.HCQ_.pills_.jpg (keep)

Just Can’t Get Enough of Hydroxychloroquine

When it comes to hydroxychloroquine dosing, issues on efficacy, toxicity and therapeutic thresholds may affect the optimal use of this important drug. Following are three abstracts presented during the meeting that address these topics.

Read Article
male.female.sexist.jpg

Gender Differences in Axial Spondyloarthritis

Rheumatic conditions such as SLE and RA exhibit female predominance. In contrast, increasing evidence suggests that gender differences occur in axial spondyloarthritis in terms of time to diagnosis, clinical manifestations, treatment outcomes and quality of life.

Read Article
Lab work

Repetitive Testing of Anti-dsDNA Antibodies May Predict Flares in SLE

In abstract #0327 presented during the poster session on Saturday, Dr. Ai Li Yeo and colleagues investigated the usefulness of serial anti-dsDNA testing in predicting flares among SLE patients who have persistently positive anti-dsDNA titers. 

Read Article
Malar,rash,SLE, Lupus

Predictors of Remission and Low Disease Activity in SLE

A treat-to-target strategy has been shown to improve clinical outcomes in patients with rheumatic diseases like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis including systemic lupus erythematosus.  The goal of treatment in SLE is aimed at remission or low disease activit

Read Article
pain.jpg

Identifying Gaps in axSpA: Lessons from European Map of Axial Spondyloarthritis (EMAS)

Despite the increasing scientific knowledge on axSpAs, a substantial gap still remains. Delay in diagnosis continues to pose a threat in the early identification of patients and those already on treatment may deal with additional issues such as work productivity or quality of life.

Read Article